Drugly News Center

Stay updated with the latest FDA drug approvals, platform updates, and pharmaceutical breakthroughs

FDA Latest FDA Drug Approvals

FDA APPROVED 23 December 2025

First orally given GLP-1 Agonist has just been approved by the FDA!

Drug: Semaglutide (Semaglutide)

The American Food and Drug Administration (FDA) has just approved the orally given Semaglutide, being sold under the brand name of Wegovy, Novo Nordisk, for the treatment of obesity and maintain weight reduction long term and to reduce the risk of major adverse cardiovascular events, as the first GLP-1 agonist...

23 December 2025
23 views
Read Full Announcement
FDA APPROVED 09 October 2025

Nerandomilast FDA Approval

Drug: Nerandomilast (Nerandomilast)

Today, the FDA has announced that Nerandomilast, being sold under the brand name Jascayd, has just been approved for the treatment of idiopathic pulmonary fibrosis (IPF), which is very rare, serious and progressive disease with very limited treatment options...

09 October 2025
26 views
Read Full Announcement
FDA APPROVED 30 September 2025

Remibrutinib FDA Approval

Drug: Remibrutinib (Remibrutinib)

On 30th of September, 2025, the Food and Drug Administration (FDA) announced that Remibrutinib has been approved for use in chronic spontaneous urticaria (CSU) in adult patients who remain symptomatic despite receiving H1-antihistamine treatment.

Remibrutinib is being sold under the...

30 September 2025
22 views
Read Full Announcement

Cosmetics Blog Posts

Product Launch 42
Effaclar Micro-Peeling Purifying Gel Cleanser

Hi all!You can now see the new product by La Roche-Posay via this link!

Drugly Team
04 Dec 2025
Read

Platform Updates & Announcements

ANNOUNCEMENT
GLP-1 Receptor Agonists and Anemia?

Hi! Have you been recently taking a GLP-1 Receptor Agonist such as Semaglutide, Liraglutide or Tirzepatide? Then, you should absolutely read this out! It must be going good for...

18 December 2025 64 views
Read More
DRUG UPDATE
Drug Updated: Acetaminophen

Acetaminophen details have been updated on Drugly.

14 December 2025 30 views
Read More
ANNOUNCEMENT
Mounjaro is now recommended to children with type II diabetes!

The European Medicines Agency (EMA) has extended the use of Mounjaro (Tirzepatide) for the treatment of type 2 diabetes in adolescents and children who are at the age of 10 or...

12 December 2025 106 views
Read More
ANNOUNCEMENT
First-ever product-specific mAb by EMA has just been published!

🚨 First-ever product-specific mAb monograph is here! European Pharmacopoeia just adopted Golimumab (3187 + 3103), 7 new mAb texts, and a dedicated SEC method for recombinant...

09 December 2025 33 views
Read More
ANNOUNCEMENT
Receptor-Ligand Interaction Simulator

Hi everyone, Our simulator for Receptor and Ligand interaction is now available for use. You can check the following interactions: Celecoxib and Prostaglandin G/H synthase 2...

20 November 2025 24 views
Read More